Abingworth

Investment thesis

Transatlantic life sciences investment firm founded in 1987 that turns breakthrough science into medicine, backing early-stage biopharma alongside specialist strategies including clinical co-development and venture investments in public equities (VIPEs). Part of Carlyle; has invested in 100+ companies over nearly 40 years.

Notable portfolio

Sector focus